Fixed ratio drug combination treatments for solid tumors
US7842676B2 · kind B2 · utility
47Cited by
0References
7Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Oct 25, 2006 |
| Grant date | Nov 30, 2010 |
| Priority date | — |
| Expiry date | Mar 31, 2029 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61P35/00
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
Provided herein are methods for treating cancer by administering a pharmaceutical composition comprising a fixed, non-antagonistic molar ratio of irinotecan and floxuridine. Such methods are particularly useful in the treatment of cancer patients with advanced solid tumors.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.